BioMarin Pharmaceutical

                   

Prix Galien USA Announces 2008 Final Candidates

prnewswire.com     Aug 12, 2008   10 related          

Honorees for best pharmaceutical agent and best biotechnology product to be recognized at Sept. 24 gala ceremony NEW YORK, Aug. 12 /PRNewswire-USNewswire/ -- The Prix Galien USA 2008 will recognize innovative biopharmaceutical...                    

comments

[$$] Bad news hits U.S. stocks (at The Wall Street Journal Online)

yahoo.com     Aug 8, 2008          

Word Count: 303 | Companies Featured in This Article: American International Group, Wal-Mart Stores, Limited Brands, J.C. Penney, Freddie Mac, Fannie Mae, Ambac Financial Group, MBIA, King Pharmaceuticals, Novo Nordisk,...                    

comments

Biotech Stocks: Drug stocks retreat, King tumbles on earnings

marketwatch.com     Aug 7, 2008   10 related          

By Val Brickates Kennedy, MarketWatch BOSTON (MarketWatch) -- Drug stocks retreated in early action Thursday as shares of King Pharmaceuticals plunged after the company issued a weaker-than-expected earnings report. The Amex...                    

comments

                   

BioMarin Pharmaceutical, Inc. Q2 2008 Earnings Call Transcript

seekingalpha.com     Aug 6, 2008   2 related          

posted on: August 06, 2008 | about stocks: BMRN Executives Eugenia Shen - Results may differ materially depending on the progress of BioMarin's product programs, actions of regulatory authorities, availability of capital,...                    

comments

Biomarin Pharmaceutical (BMRN) NewsBite - Upgrade Lifts BMRN

pharmiweb.co.uk     Jul 27, 2008          

Posted on Friday, July 25, 2008 12:24 PM BioMarin Pharmaceutical Inc. (BMRN) opened at 31.12. So far today, the stock has hit a low of 31.09 and a high of 31.95. BMRN is now trading at 31.55, up 0.69 (2.20%). The stock hit its...                    

comments

BioMarin and Summit sign licensing agreement

pharmaceutical-business-review.com     Jul 24, 2008   12 related          

BioMarin Pharmaceutical and Summit have entered into an exclusive worldwide licensing agreement for Summit's novel preclinical candidate SMT C1100 and all follow-on molecules, which are being developed to treat the fatal...                    

comments

                   

Genzyme Reports Strong Second-Quarter Growth (PR Newswire)

yahoo.com     Jul 23, 2008   4 related          

Wednesday July 23, 8:30 am ET Delivers Solid Financial Performance While Building for the Future CAMBRIDGE, Mass., July 23 /PRNewswire-FirstCall/ -- "We delivered solid financial results, set in place a number of catalysts that...                    

comments

                   

Children's Memorial Hospital Of Chicago Receives A Grant From BioMarin To Support Adult PKU Outreach

medicalnewstoday.com     Jul 23, 2008          

Children's Memorial Hospital of Chicago has announced that it has received a grant from BioMarin Pharmaceutical Inc. to support its Adult Phenylketonuria (PKU) Outreach Education Project. The goal of the program is to conduct...                    

comments

Roche Scoops Up Biotech Firm

orglex.com     Jul 22, 2008          

The Swiss drug maker got a boost after acquiring Mirus Bio for $125 million.[...] Novato, CA, and Oxford, UK, July 22, 2008 BioMarin Pharmaceutical Inc. (Nasdaq and SWX: BMRN) andSummit Corporation plc (AIM: SUMM) announced...                    

comments

                   

UK small caps slide at midday; Myhome International down on covenant breach (AFX)

yahoo.com     Jul 22, 2008   3 related          

LONDON (Thomson Financial) - Myhome International shed 3.625 pence to 4-1/4 pence as it said it was in breach of some of its banking facility covenants due to a weak economic climate and reduced trading expectations. In numbers...                    

comments

1 2 3 4 5 next »